Table 1.

Patient disposition for patients receiving angiotensin receptor blocker or angiotensin-converting enzyme inhibitor monotherapy

	ARB monotherapy		ACEI monotherapy
	Lumiracoxib 100 mg od (N = 57)	Ibuprofen 600 mg tid (N = 48)	Lumiracoxib 100 mg od (N = 42)	Ibuprofen 600 mg tid (N = 40)
Completed, n (%)	53 (93.0)	47 (97.9)	39 (92.9)	38 (95.0)
Discontinued, n (%)	4 (7.0)	1 (2.1)	3 (7.1)	2 (5.0)
Death	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)
Adverse event	2 (3.5)*	0 (0.0)	1 (2.4)†	0 (0.0)
Unsatisfactory therapeutic effect	1 (1.8)	0 (0.0)	1 (2.4)	0 (0.0)
Subject withdrew consent	0 (0.0)	0 (0.0)	0 (0.0)	2 (5.0)
Protocol violation	1 (1.8)	1 (2.1)	0 (0.0)	0 (0.0)
Administrative problems	0 (0.0)	0 (0.0)	1 (2.4)	0 (0.0)

^*Upper abdominal pain (n = 1), retinal detachment (n = 1).

^†Bells palsy (n = 1).

ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blockers; od, once daily; tid, thrice daily.